Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Xeris Biopharma Holdings, Inc. company logo
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS)

Profile

Company profile for Xeris Biopharma Holdings, Inc. (XERS)
MetricValue
Full NameXeris Biopharma Holdings, Inc.
TickerNASDAQ: XERS
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitexerispharma.com
Employees394

Key Metrics

Xeris Biopharma Holdings, Inc. Key Details
MetricDateValue
Price$6.96
Price, 1D Change-1.83%
Market Cap$1B
-
PE Ratio-
Beta0.92
Revenue$203M
Revenue, 1Y Change+23.89%
EPS-$0.37
EPS, 1Y Change+17.38%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Xeris Biopharma Holdings, Inc. chart

Events

Xeris Biopharma Holdings, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

XERS Estimates
MetricDateValue
EPS-$0.37
EPS Estimate$0.06
EPS Est. Change+116.86%
Revenue$203.07M
Revenue Estimate$287.42M
Revenue Est. Change+41.54%
Current Price$6.96
Price Target-$10.00
Price Tgt. Change-+43.68%

🔒 Log In To Unlock Full Data

EPS

XERS EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.43-$0.45-5.16%
-$0.25-$0.37-52.49%
$0.06N/A+116.86%
$0.31N/A+184.18%
XERS EPS reported versus estimate values chart

Revenue

XERS revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$162.62M$163.91M+0.80%
$201.51M$203.07M+0.77%
$287.42MN/A+41.54%
$367.52MN/A+80.98%
XERS revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

XERS Performance
MetricDateValue
Price, 1Y+96.61%
Price, 3Y+562.86%
Market Cap, 1Y+118.31%
Market Cap, 3Y+707.09%
Revenue, 1Y+23.89%
Revenue, 3Y+309.50%
EPS, 1Y+17.38%
EPS, 3Y+75.94%

🔒 Log In To Unlock Full Data

Technical Indicators

XERS Technical Indicators
MetricDateValue
Current Price$6.96
SMA 200$6.37
SMA 200 vs Price-8.46%
SMA 50$7.59
SMA 50 vs Price+9.03%
Beta0.92
ATR$0.39
14-Day RSI43.95
10-Day Volatility58.46%
1-Year Volatility61.79%

Dividends

XERS Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

XERS Income & Profitability
MetricDateValue
Revenue$203.07M
EPS-$0.37
Gross Profit$166.24M
Gross Margin76.52%
Operating Profit-$33.65M
Operating Margin-16.57%
Net Income-$54.84M
Net Margin-27.00%
EBITDA-$13.99M

🔒 Log In To Unlock Full Data

Financial Health

XERS Financial Health
MetricDateValue
Debt To Equity-7.84
Current Ratio1.67
Quick Ratio1.19
Interest Coverage-0.87
F-Score5
Altman Z-Score-0.33

Valuations

XERS Valuations
MetricDateValue
PE Ratio-
PS Ratio4.34
PB Ratio-1,341.74
EV/EBITDA58.89
Enterprise ValueN/A-

Balance Sheet

XERS Balance Sheet
MetricDateValue
Book Value-$29.62M
Cash & Equivalents$71.62M
Total Assets$329.15M
Current Assets$167.66M
Total Liabilities$358.77M
Current Liabilities$100.44M
Total Debt$271.45M
Short Term Debt$21.18M
Accounts Payable$2.29M

Expenses

XERS Expenses
MetricDateValue
Total Expenses$236.72M
Operating Expenses$199.88M
Cost Of Goods Sold$47.68M
SG&A$163.48M
D&A$12.63M
Interest Expense$30.49M
Income Tax-$2.27M

Cash Flow

XERS Cash Flow
MetricDateValue
CFO-$36.98M
CFI$4.88M
CFF$36.17M
Capex$868.00K
Free Cash Flow-$37.85M

Recent analyst updates

XERS Recent analyst updates
MetricDateValue
Barclays
Piper Sandler→
Oppenheimer→
HC Wainwright & Co.→
Oppenheimer→
HC Wainwright & Co.→
Leerink Partners→
Oppenheimer→
Craig-Hallum→
Leerink Partners→

Analyst sentiment

Sentiment over the past month
XERS analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
XERS institutional ownership distribution chart

Screeners with XERS

Data Sources & References

  1. XERS Official Website www.xerispharma.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1867096/000186709625000159/0001867096-25-000159-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1867096/000186709625000039/0001867096-25-000039-index.htm
  4. XERS Profile on Yahoo Finance finance.yahoo.com/quote/XERS
  5. XERS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/xers

FAQ

  • What is the ticker symbol for Xeris Biopharma Holdings, Inc.?

    The ticker symbol for Xeris Biopharma Holdings, Inc. is NASDAQ:XERS

  • Does Xeris Biopharma Holdings, Inc. pay dividends?

    No, Xeris Biopharma Holdings, Inc. does not pay dividends

  • What sector is Xeris Biopharma Holdings, Inc. in?

    Xeris Biopharma Holdings, Inc. is in the Healthcare sector

  • What industry is Xeris Biopharma Holdings, Inc. in?

    Xeris Biopharma Holdings, Inc. is in the Biotechnology industry

  • What country is Xeris Biopharma Holdings, Inc. based in?

    Xeris Biopharma Holdings, Inc. is headquartered in United States

  • When did Xeris Biopharma Holdings, Inc. go public?

    Xeris Biopharma Holdings, Inc. initial public offering (IPO) was on June 21, 2018

  • Is Xeris Biopharma Holdings, Inc. in the S&P 500?

    No, Xeris Biopharma Holdings, Inc. is not included in the S&P 500 index

  • Is Xeris Biopharma Holdings, Inc. in the NASDAQ 100?

    No, Xeris Biopharma Holdings, Inc. is not included in the NASDAQ 100 index

  • Is Xeris Biopharma Holdings, Inc. in the Dow Jones?

    No, Xeris Biopharma Holdings, Inc. is not included in the Dow Jones index

  • When was Xeris Biopharma Holdings, Inc. last earnings report?

    Xeris Biopharma Holdings, Inc.'s most recent earnings report was on November 6, 2025

  • When does Xeris Biopharma Holdings, Inc. report earnings?

    The next expected earnings date for Xeris Biopharma Holdings, Inc. is March 5, 2026